{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:46:44Z","timestamp":1793915204145,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2018\/29\/N\/ST5\/01543"],"award-info":[{"award-number":["2018\/29\/N\/ST5\/01543"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioadv.2025.214363","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:04:30Z","timestamp":1748433870000},"page":"214363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Engineered lipid nanoparticles loaded with LL-37 peptide as inhalable drug delivery carriers for the treatment of bacterial infections"],"prefix":"10.1016","volume":"176","author":[{"given":"Katarzyna","family":"Reczy\u0144ska-Kolman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Ocho\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Brzychczy-W\u0142och","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Pamu\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/thx.53.1.58","article-title":"Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection","volume":"53","author":"Stockley","year":"1998","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.bioadv.2025.214363_bb0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/v13091725","article-title":"Viral and bacterial co-infections in the lungs: dangerous liaisons","volume":"13","author":"Oliva","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41579-022-00821-x","article-title":"The dynamic lung microbiome in health and disease","volume":"21","author":"Natalini","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214363_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/CPM.0000000000000108","article-title":"Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilms","volume":"23","author":"Pragman","year":"2016","journal-title":"Clin. Pulm. Med."},{"key":"10.1016\/j.bioadv.2025.214363_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2022.100089","article-title":"Interplay between biofilm microenvironment and pathogenicity of Pseudomonas aeruginosa in cystic fibrosis lung chronic infection","volume":"4","author":"Guillaume","year":"2022","journal-title":"Biofilm"},{"issue":"9","key":"10.1016\/j.bioadv.2025.214363_bb0030","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cells11091416","article-title":"Respiratory viral and bacterial exacerbations of COPD\u2014the role of the airway epithelium","volume":"11","author":"Love","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bioadv.2025.214363_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmicb.2013.00047","article-title":"The multifaceted roles of antibiotics and antibiotic resistance in nature","volume":"4","author":"Sengupta","year":"2013","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0040","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12223-016-0462-y","article-title":"Biogenesis of antibiotics\u2014viewing its history and glimpses of the future","volume":"61","author":"Sp\u00ed\u017eek","year":"2016","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.bioadv.2025.214363_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213684","article-title":"A systematical review on antimicrobial peptides and their food applications","volume":"155","author":"Xu","year":"2023","journal-title":"Biomaterials Advances"},{"key":"10.1016\/j.bioadv.2025.214363_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213641","article-title":"Highly active nisin coated polycaprolactone electrospun fibers against both Staphylococcus aureus and Pseudomonas aeruginosa","volume":"154","author":"Dart","year":"2023","journal-title":"Biomaterials Advances"},{"issue":"6","key":"10.1016\/j.bioadv.2025.214363_bb0060","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41564-018-0164-0","article-title":"Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides","volume":"3","author":"L\u00e1z\u00e1r","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214363_bb0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11095-022-03379-8","article-title":"Pulmonary delivery of emerging antibacterials for bacterial lung infections treatment","volume":"40","author":"Li","year":"2023","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214363_bb0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","article-title":"Antibacterial peptides for therapeutic use: obstacles and realistic outlook","volume":"6","author":"Marr","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bioadv.2025.214363_bb0075","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1021\/acs.molpharmaceut.6b00099","article-title":"Nanoparticles encapsulated with LL37 and serpin a1 promotes wound healing and synergistically enhances antibacterial activity","volume":"13","author":"Fumakia","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214363_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fmicb.2011.00128","article-title":"Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37","volume":"2","author":"Dean","year":"2011","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0085","doi-asserted-by":"crossref","DOI":"10.1116\/6.0001981","article-title":"New antimicrobial peptide-antibiotic combination strategy for Pseudomonas aeruginosa inactivation","volume":"17","author":"Han","year":"2022","journal-title":"Biointerphases"},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11274-023-03545-z","article-title":"Antibiofilm properties of cathelicidin LL-37: an in-depth review","volume":"39","author":"Memariani","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214363_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12342","article-title":"Mucus as a barrier to drug delivery\u2013understanding and mimicking the barrier properties","volume":"116","author":"Boegh","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.bioadv.2025.214363_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206602","article-title":"Advances of antimicrobial peptide-based biomaterials for the treatment of bacterial infections","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214363_bb0105","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/acsbiomaterials.0c01084","article-title":"Albumin-based LL37 peptide nanoparticles as a sustained release system against Pseudomonas aeruginosa lung infection","volume":"7","author":"Yang","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"3","key":"10.1016\/j.bioadv.2025.214363_bb0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/antibiotics12030484","article-title":"Current and emerging inhaled antibiotics for chronic pulmonary Pseudomonas aeruginosa and Staphylococcus aureus infections in cystic fibrosis","volume":"12","author":"Li","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arbres.2021.03.009","article-title":"Effectiveness and safety of inhaled antibiotics in patients with chronic obstructive pulmonary disease. A multicentre observational study","volume":"58","author":"De la Rosa Carrillo","year":"2022","journal-title":"Arch. Bronconeumol."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.xphs.2020.09.006","article-title":"Contemporary formulation development for inhaled pharmaceuticals","volume":"110","author":"Sou","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214363_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbac099","article-title":"Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations","volume":"10","author":"Knap","year":"2023","journal-title":"Regen. Biomater."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214363_bb0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/antibiotics12020267","article-title":"How to use nebulized antibiotics in severe respiratory infections","volume":"12","author":"Gorham","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bioadv.2025.214363_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/pharmaceutics16070878","article-title":"Solid lipid nanoparticles loaded with dexamethasone palmitate for pulmonary inflammation treatment by nebulization approach","volume":"16","author":"Chen","year":"2024","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.bioadv.2025.214363_bb0145","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.bioadv.2025.214363_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17425247.2021.1854222","article-title":"Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung","volume":"18","author":"Chen","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0155","first-page":"34","article-title":"A comprehensive review on novel lipid-based nano drug delivery","volume":"14","author":"Godase","year":"2024","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10.1016\/j.bioadv.2025.214363_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104709","article-title":"Solid lipid nanoparticles: an effective lipid-based technology for cancer treatment","volume":"86","author":"Akanda","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"7","key":"10.1016\/j.bioadv.2025.214363_bb0165","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/acs.molpharmaceut.4c00128","article-title":"Solid lipid nanoparticles for pulmonary delivery of biopharmaceuticals: a review of opportunities, challenges, and delivery applications","volume":"21","author":"Alwani","year":"2024","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0170","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsnano.4c13053","article-title":"Nebulized lipid nanoparticles based on degradable ionizable glycerolipid for potent pulmonary mRNA delivery","volume":"19","author":"Huang","year":"2025","journal-title":"ACS Nano"},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2025.214363_bb0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","article-title":"Solid lipid nanoparticles for pulmonary delivery of insulin","volume":"356","author":"Liu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214363_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124876","article-title":"Stearic acid-based nanoparticles loaded with antibacterial peptides \u2013 Bacitracin and LL-37: selection of manufacturing parameters, cytocompatibility, and antibacterial efficacy","volume":"667","author":"Reczy\u0144ska-Kolman","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bioadv.2025.214363_bb0185","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1021\/acsbiomaterials.0c01728","article-title":"Modeling airway dysfunction in asthma using synthetic mucus biomaterials","volume":"7","author":"Song","year":"2021","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.bioadv.2025.214363_bb0190","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0195","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1038\/s41598-021-86037-0","article-title":"Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium","volume":"11","author":"Sanchez-Guzman","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bioadv.2025.214363_bb0200","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3109\/03639041003695113","article-title":"Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model","volume":"36","author":"Haghi","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9","key":"10.1016\/j.bioadv.2025.214363_bb0205","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/19\/9\/095701","article-title":"The effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles","volume":"19","author":"Ruktanonchai","year":"2008","journal-title":"Nanotechnology"},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/pharmaceutics17010108","article-title":"Curcumin-loaded lipid nanoparticles: a promising antimicrobial strategy against enterococcus faecalis in endodontic infections","volume":"17","author":"Ferreira","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214363_bb0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.actbio.2020.12.024","article-title":"Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique","volume":"121","author":"Arduino","year":"2021","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.bioadv.2025.214363_bb0220","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/sia.3831","article-title":"XPS analysis of bio-organic systems","volume":"43","author":"Rouxhet","year":"2011","journal-title":"Surf. Interface Anal."},{"issue":"12","key":"10.1016\/j.bioadv.2025.214363_bb0225","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sia.6843","article-title":"Hard and soft X-ray photoelectron spectroscopy for selective probing of surface and bulk chemical compositions in a perovskite-type Ni catalyst","volume":"52","author":"Sambalova","year":"2020","journal-title":"Surf. Interface Anal."},{"key":"10.1016\/j.bioadv.2025.214363_bb0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.actbio.2021.08.046","article-title":"Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin","volume":"135","author":"Cheng","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2025.214363_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122661","article-title":"Airway mucus in pulmonary diseases: muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers","volume":"634","author":"Pangeni","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0240","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/acsbiomaterials.2c00047","article-title":"Untangling mucosal drug delivery: engineering, designing, and testing nanoparticles to overcome the mucus barrier","volume":"8","author":"Watchorn","year":"2022","journal-title":"ACS Biomater Sci. Eng."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0245","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/acs.biomac.6b00164","article-title":"Size-limited penetration of nanoparticles into porcine respiratory mucus after aerosol deposition","volume":"17","author":"Murgia","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioadv.2025.214363_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-020-04785-y","article-title":"Effect of particle size and surface charge of nanoparticles in penetration through intestinal mucus barrier","volume":"22","author":"Bandi","year":"2020","journal-title":"J. Nanopart. Res."},{"issue":"7","key":"10.1016\/j.bioadv.2025.214363_bb0255","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.nano.2016.04.006","article-title":"Mucus-penetrating nanoparticles made with \u201cmucoadhesive\u201d poly (vinyl alcohol)","volume":"12","author":"Popov","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214363_bb0260","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fbioe.2020.00561","article-title":"Evaluation of nisin and LL-37 antimicrobial peptides as tool to preserve articular cartilage healing in a septic environment","volume":"8","author":"Najmi","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioadv.2025.214363_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170432","article-title":"LL-37-induced caspase-independent apoptosis is associated with plasma membrane permeabilization in human osteoblast-like cells","volume":"135","author":"Bankell","year":"2021","journal-title":"Peptides"},{"key":"10.1016\/j.bioadv.2025.214363_bb0270","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1007\/s13346-021-00921-w","article-title":"Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy","volume":"11","author":"Thorn","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2025.214363_bb0275","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2018.11.017","article-title":"Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides","volume":"134","author":"Gonz\u00e1lez-Paredes","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214363_bb0280","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2019.02.039","article-title":"Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm","volume":"300","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214363_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.214027","article-title":"Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections\u2013development and in-vitro characterization","volume":"166","author":"Chauhan","year":"2025","journal-title":"Biomaterials Advances"},{"issue":"7","key":"10.1016\/j.bioadv.2025.214363_bb0290","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/jat.4101","article-title":"Genotoxicity and subchronic toxicity studies of Lipocet\u00ae, a novel mixture of cetylated fatty acids","volume":"41","author":"Brilli","year":"2021","journal-title":"J. Appl. Toxicol."},{"issue":"6","key":"10.1016\/j.bioadv.2025.214363_bb0295","first-page":"539","article-title":"Solid lipid nanoparticles (SLN)\u2013effects of lipid composition on in vitro degradation and in vivo toxicity","volume":"61","author":"Weyhers","year":"2006","journal-title":"Die Pharmazie-An International Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.bioadv.2025.214363_bb0300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(01)00882-1","article-title":"Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages","volume":"231","author":"Sch\u00f6ler","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214363_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejps.2018.10.003","article-title":"Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization","volume":"125","author":"Nafee","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2025.214363_bb0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2010.02.014","article-title":"A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung","volume":"75","author":"Nassimi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.bioadv.2025.214363_bb0315","article-title":"Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery","volume":"2013","author":"Varshosaz","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioadv.2025.214363_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2018.01.001","article-title":"A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the 3H-labelled structural lipids after pulmonary delivery in rats","volume":"125","author":"Haque","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.bioadv.2025.214363_bb0325","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bioadv.2025.214363_bb0330","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425247.2015.1039509","article-title":"Nano-and micro-based inhaled drug delivery systems for targeting alveolar macrophages","volume":"12","author":"Lee","year":"2015","journal-title":"Expert Opin. Drug Deliv."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825001906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825001906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:35:32Z","timestamp":1762648532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"alternative-id":["S2772950825001906"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214363","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered lipid nanoparticles loaded with LL-37 peptide as inhalable drug delivery carriers for the treatment of bacterial infections","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214363"}}